Wednesday, 16 October 2019

Drug Discovery News

  • Tetraphase antibiotic gets FDA QIDP designation

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: US-based Tetraphase Pharmaceuticals has received approval from US FDA for its lead antibiotic product candidate, eravacycline, as a Qualified Infectious Disease Product (QIDP).QI...Read more

  • Zhejiang Medicine, Ambrx to develop antibody drug conjugate for breast cancer

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced interna...Read more

  • Novartis to ship 30 mn flu vaccine to US

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Novartis plans to ship around 30 million doses of its influenza vaccines including Fluvirin and Flucelvax to customers in the US market for the 2013-2014 season. In clinical stud...Read more

  • FDA warns Genentech researcher for trial data validity

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

    Singapore: The US FDA has given a warning to Dr Bernard Doft, a phase III investigator of Genentech's Lucentis macular degeneration treatment, for failing to follow the protocol and maintai...Read more

  • Pall to acquire Atmi for $185 million

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Feb, 2014

    Singapore: Pall Corporation, a developer of filtration, separation and purification technology, has decided to acquire Atmi LifeSciences, a technology company in the field of single-use bio...Read more

  • Now 9-yr-old girls can use Cervarix for cancer

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 07 May, 2013

    Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, premalignant cervical lesions and cervical cancer caused by Human Papillo...Read more

  • Novotech to support drug development in Korea

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2014

    Singapore: Australian clinical research organization, Novotech, has partnered with Korea Drug Development Fund (KDDF) to promote development of Korean biotechnology sector in the Asia Pacif...Read more

  • Xiangxue Pharma acquires rights for Kinex KX02

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

    Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceuticals exclusive rights to Kinex's KX02 for all oncology indications i...Read more

  • Alchemia appoints new chairman

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2014

    Singapore: Alchemia, Australia based drug discovery and development company, has appointed Mr. Santo J. Costa as non-executive Chairman of the Board of Directors, effective as of 1 March 20...Read more

  • Bionomics, Merck Serono end agreement

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

    Singapore: Australian company Bionomics and Merck Serono, a division of Merck, Darmstadt Germany, have mutually ended their agreement to jointly develop new treatments for MS and other aut...Read more

  • Chinese, Hong Kong scientists map H7N9 risk infection

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2013

    Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production and consumption, which can be used to determine future risk and advis...Read more

  • AstraZeneca, Alchemia sign $240 mn drug deal

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Apr, 2013

    Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the use of the proprietary Diversity Scanning Array (DSA) and associated...Read more

  • Takeda gets Japanese NDA approval for obesity drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Sep, 2013

    Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labour and Welfare approval for the new drug application (NDA) of Oblean ...Read more

  • Lilly reveals phase III trial data on back pain

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

    Singapore: Eli Lilly and Company published data from a phase III trial comparing the effects of FORTEO (teriparatide, rDNA origin injection) and risedronate on back pain in postmenopausal w...Read more

  • Takeda's diabetes drug gets Chinese FDA nod

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: Japanese major Takeda Pharmaceutical has said that the China's State Food and Drug Administration (SFDA) has issued them an Import Drug License (IDL) for Nesina (alopliptin) for ...Read more

  • Aveo, Astellas report cancer trial results

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2013

    Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, from the phase III TIVO-1 (Tivozanib versus sorafenib in first line adv...Read more

  • UK, Belgium nod for Bone Therapeutics' therapy

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2013

    Singapore: Europe-based Bone Therapeutics, a biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases, received clearance from authorities in...Read more

  • Japan, Singapore to bring innovation in drug, device, technology

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2013

    Singapore: Japan's Kanagawa Prefecture's Global Collaboration Center for Life Innovation (GCC) and the Agency for Science, Technology and Research (A*Star), the National University of Singa...Read more



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls